About
Anil Achyuta is the Director of External Innovation at L’Oréal, where he invests in next-generation technologies in materials science, digital / skin health, and medical aesthetics. Previously, Anil advised GlaxoSmithKline's (GSK) Bioelectronics R&D division and their Venture Arm – Action Potential Ventures (APVC) as their Associate Consulting Director (now a $750M joint venture between GSK and Google’s Verily). Anil also created, led, and launched GSK's $1M Innovation Challenge, an open global competition. The Innovation Challenge catalyzed several strategic privatepublic partnerships and was designed to closely complement President Obama's BRAIN Initiative. Before GSK, Anil worked at Draper’s Business Development leading strategic projects in lab-on-a-chip, tissue engineering, and implantable devices. In lab-on-a-chip devices arena, Anil co-led the liver and brain-on-a-chip concepts, where his team showed malarial infections inside the liver chip (Gates foundation funded project). F
Position in the VCSift Database
- • 4 investors at TDK Ventures are tracked.
- • 165 investors hold the Investment Director role in VCSift. Anil Achyuta is one of them.
- • 2,293 investors are based in Boston, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Boston, US
Contact Information
Find more investors like Anil
Search Investors